Esquenazi, A., Feng, W. W., Wittenberg, G., Gallien, P., Baricich, A., Fanning, K., … Bandari, D. (2020). Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study. In NEUROLOGY (Vol. 94).

Esquenazi, Alberto, Wuwei Wayne Feng, George Wittenberg, Philippe Gallien, Alessio Baricich, Kristina Fanning, Aleksej Zuzek, Gerard Francisco, and Daniel Bandari. “Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study.” In NEUROLOGY, Vol. 94, 2020.

Esquenazi A, Feng WW, Wittenberg G, Gallien P, Baricich A, Fanning K, et al. Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study. In: NEUROLOGY. 2020.

Esquenazi, Alberto, et al. “Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study.” NEUROLOGY, vol. 94, no. 15, 2020.

Esquenazi A, Feng WW, Wittenberg G, Gallien P, Baricich A, Fanning K, Zuzek A, Francisco G, Bandari D. Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study. NEUROLOGY. 2020.